Document:

<PAGE>

                                                                   Exhibit 10.20

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                  - Year 2000 -

                                                                   APPROVED
                                                               BY Resolution
                                                                  ----------
                                                               DATE 1/25/00
                                                                    --------

The RTI annual Incentive Compensation Plan incorporates the following three
separate plans:

      o     RTI Corporate Plan
      o     Sales & Marketing Plan
      o     National Accounts/Recovery Plan

Employees only participate in one of the Plans. Plan participants from the Sales
& Marketing Plan and the National Accounts/Recovery Plan are not eligible as
participants in the RTI Corporate Plan.

Index:
                                                                 Page
                                                                 ----

      Sales & Marketing Plan                                       2
      National Accounts/Donor Recovery Plan                        3
      RTI Corporate Plan                                         4-7
      Administrative & Operating Provisions                        8
      Revenue, Profit & Plan Income for 2000                       9
      Summary of Plan Pay-Outs                                    10
      Spreadsheet: Sales & Marketing Plan                         11
      Spreadsheet: National Accounts/Donor Recovery Plan          12
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                  - Year 2000 -

Sales & Marketing Plan:

The following employees are participants in the Sales & Marketing Plan.

              Participants -
                  VP Sales
                  National Sales Director
                  Regional Sales Managers
                  Distribution Manager
                  Oral-Maxillofacial Group

How Sales & Marketing Plan awards are computed:

The Sales & Marketing Plan establishes, for each product group under the
employee's control:

      o     Baseline sales volumes
      o     "Budget" sales volumes (external goals)
      o     "Internal Target" sales volumes (optimistic goals)

For each product group, the potential award is calculated as a pre-determined
percentage of the sales over baseline and over Budget.

VP and Director-level participants in the Sales & Marketing Plan, like Officer &
Director-level participants in the RTI Corporate Plan, do not achieve any awards
unless sales equal to the "Budget" levels are achieved.

Full Plan Computation:

The attached spreadsheet titled "Year 2000 Sales & Marketing Incentive Plans" on
page 11 reflects the specific baselines, percentages and proposed bonuses at
Budget, Target and 110% of Target for all participants in the Sales & Marketing
Plan.

                                       2
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                  - Year 2000 -

National Accounts/Donor Recovery Plan:

The following employees are participants in the National Accounts/Donor Recovery
Plan.

              Participants -
                  Dan Towers, National Recovery Manager
                  Stacey Barron, National Recovery Manager
                  Kathy Croft, National Recovery Manager

How National Accounts/Donor Recovery awards are computed:

The National Accounts/Donor Recovery Plan establishes bonuses for adding new
recovery groups or increasing donor recovery in the territory's or programs
under the employee's control. Bonus programs include:

      o     Adding new recovery groups (% based on # of donors)
      o     Adding contracts that decrease average per-donor recovery cost
      o     Overachieving donor recovery in existing territories
      o     Adding funeral homes to the recovery network
      o     Adding medical examiner recovery of heart valves
      o     Converting or signing "Management Services Agreements"

Full Plan Computation:

The attached spreadsheet titled "Year 2000 National Accounts / Donor Recovery
Incentive Plan" on page 12 reflects the specific bonuses and targets for each
aspect of this Plan, for all participants in the National Accounts / Donor
Recovery Plan

                                       3
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                  - Year 2000 -

RTI Corporate Plan:

All employees who are not participants in the Sales & Marketing Plan or the
National Accounts/Donor Recovery Plan will be eligible to participate in the RTI
Corporate Plan.

The RTI Corporate Plan has the following participant levels:

                                                        Participant
            Job Levels                                     Group
               CEO/CFO/COO                                    I
               Vice Presidents                               II
               Directors                                    III
               Managers                                      IV
               Exempt                                         V
               Non-Exempt                                    VI

Calculating the Incentive Pool under the RTI Corporate Plan:

The pool of funds that is available for incentives under the RTI Corporate Plan
is computed as a percentage of the company's performance over budgetary targets.
For 2000, that overall corporate target is:

      o     Overall corporate Pre-Tax Operating Income above the Budget level

Each department within the company has other targets which must be achieved in
order to achieve full participation in the pool of funds that is available.
These departmental targets include such items as corporate revenue above
baselines, product-line revenue above baselines, new product introductions, etc.

How Individual awards are computed in the RTI Corporate Plan:

Incentive award opportunities in the RTI Corporate Plan are computed based on
the following factors:

      o     Overall Corporate Performance (above)
      o     Achievement of Departmental Goals & Metrics
      o     Individual Performance

Participants in the RTI Corporate Plan do not achieve any awards unless profits
are above to the company's "Budget" level for profits.

                                       4
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                  - Year 2000 -

RTI Corporate Plan, cont.:

Computing the Pool Available for the RTI Corporate Plan:

The pool of funds potentially available for pay-out under the RTI Corporate Plan
is computed as follows:

          If Plan Income* is at or below RTI's "Budget" for Plan Income:
                  -0-Funding of Pool

          If Plan Income is above "Budget" for Plan Income:
              + 30.0% of Plan Income above "Budgeted" Plan Income

"Budgeted Net Income" for Year 2000 does not include any incentive compensation
expense, as no incentive compensation is earned until earnings exceed Budgeted
Net Income.

Examples of Pool Available at "Budget" & "Internal Target":

                                                       At        At      At 110%
                                                     Budget    Target     Target
      Computed "Plan Income"                         $9.7m     $14.4m    $17.3m
      RTI Corporate Incentive Pool Available         $ -0-     $1.4m     $2.3m
      RTI Corporate After-Tax Net income             $5.8m     $7.8m     $9.Om

"Plan Income" = Net Operating Income before Tax or RTI Corporate Incentive Plan
expense

                                       5
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                  - Year 2000 -

RTI Corporate Plan, cont.:

Division of the Pool Among Participant Groups:

Assuming an incentive pool is earned as described above, the pool will be
divided initially among the six categories of employees as reflected below,
creating six sub-pools. The percentage for each sub-pool has been calculated to
result in a potential pay-out, if the company achieves it's Internal Profit
Target (above "Budget"), of the following multiple of "base compensation":

                                            % of Base Pay          % of Pool
      Job Levels            Group         at Internal Target        Required
          CEO/CFO/COO          I         35% of base earnings     14.2% of Pool
          Vice Presidents      II        30% of base earnings      8.3% of Pool
          Directors            III       25% of base earnings     20.4% of Pool
          Managers             IV        15% of base earnings     18.8% of Pool
          Exempt               V         10% of base earnings     17.6% of Pool
          Non-Exempt           VI             5% of earned(1)     20.7% of Pool

      1.    Expressed as a percentage of earnings, including overtime payments,
            for non-exempt participants, in order to prevent overtime from being
            used to increase the "base wages" qualifying for incentives.

All individual pay-outs from the sub-pools will be dependent upon achievement of
Department goals and individual performance, and subject to executive review.

No pay-out exists if the company only achieves the "Budget" level of Net Income.
At 110% of "Internal Target" Net Profit, the pay-outs are estimated to be
roughly 60% higher for each bracket than the percentages shown above. Page 9,
"Revenue, Profit & Plan Income for 2000 Budget Year," reflects the pay-outs
projected, by category, at Budget, Internal Target, and 110% of Internal Target.

                                       6
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                   -Year 2000-

RTI Corporate Plan, cont.:

Recap:

1.    The "Incentive Pool" will only exist if the company achieves its Budgeted
      Net Profit level
2.    After Budgeted Net Profit level is achieved, the Pool is increased only as
      a percentage of earnings above the Budget
3.    Employees will still be required to achieve Departmental goals to
      participate in the potential Pool
4.    Individual performance will be used to determine the final pay-out (if
      any) from the pool
5.    A review of all proposed pay-outs under the Plan will be conducted by the
      company's CEO, COO and CEO prior to any pay-outs

Specific goals of each Department (or Business Unit) will be weighted based on
importance

                                       7
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -
                                   -Year 2000-

RTI Corporate Plan, cont.:

Operational Provisions of Plan:

      --    Participant award ranges reviewed and approved annually
      --    Organizational performance measures reviewed and approved annually
      --    Review of extraordinary items affecting financial results will be
            conducted annually, with appropriate adjustments made in determining
            the bonus pool funding level
      --    Individual contribution to RTI success reviewed annually
      --    The plan may be amended or discontinued by RTI at anytime
      --    RTI maintains the right to change or terminate any individual's
            participation in the Plan at any time
      --    Nothing in the plan shall confer on any participant the right to
            continued employment or affect RTI's right to terminate a
            participant's employment for any reason

Administrative Guidelines:

      --    Full participation if employed throughout the fiscal year;
      --    Partial participation if a participant enters the plan in the first
            nine months of the year;
      --    Employees joining in 4Q are excluded;
      --    Pro-rata participation at regular distribution date if termination
            occurs due to death, total disability, retirement or layoff;
      --    No award for other types of termination prior to end of fiscal year;
      --    No award for participants evaluated unsatisfactory on
            performance/appraisal;
      --    If promotion results in a change in target bonus prior to the fourth
            quarter, final award is pro-rated based on the number of months at
            each level.

End-of-Year Administrative Steps:

      --    Compute amount (if any) of Incentive Pool
      --    Approve plan participants
      --    Review status of Departmental goals
      --    Approve final incentive awards
      --    CEO/CFO/COO review individual performance

                                       8
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -

             Revenue, Profit and "Plan Income" for 2000 Budget Year

<TABLE>
<CAPTION>
                                                   -----------------     --------------------    ------------------
                                                       Year 2000               Year 2000              Year 2000
Per Budget & internal Targets:                           Budget             Internal Target       110% of Int Targ
                                                   -----------------     --------------------    ------------------

          <S>                                         <C>                     <C>                    <C>
          Gross Revenue                               124,259,764             137,701,701            151,471,871

          Net Revenue                                  62,422,314              68,782,367             75,660,604

          Net income from Operations             *      9,675,730              12,961,900             15,008,176

          Net Pre-Tax Income                            9,713,730              12,999,900             15,046,176

          Net Income                                    5,828,238               7,799,940              9,027,706
                                                   -----------------     --------------------    ------------------

<CAPTION>
                                                   -----------------     --------------------    ------------------
                                                       Year 2000               Year 2000              Year 2000
Computed for Plan Purposes:                              Budget             Internal Target       110% of Int Targ
                                                   -----------------     --------------------    ------------------

          <S>                                           <C>                    <C>                    <C>
          Pre-Tax Operating income (from above)  *      9,675,730              12,961,900             15,008,176

          RTI Corporate incentive Compensation                 --               1,405,000              2,281,975

          "PLAN INCOME" (computed)                      9,675,730              14,366,900             17,290,151
                                                   -----------------     --------------------    ------------------

<CAPTION>
                                                   -----------------     --------------------    ------------------
                                                       Year 2000               Year 2000              Year 2000
Incentive Comp as % of Pre-Tax Income:                   Budget             Internal Target       110% of Int Targ
                                                   -----------------     --------------------    ------------------

          <S>                                                  <C>              <C>                    <C>
          Incentive Compensation (above)                       --               1,405,000              2,281,975

          % of "Plan income over Budget"                       0%                     30%                    30%

          % of Pre-Tax Operating Income                        0%                     11%                    15%
                                                   -----------------     --------------------    ------------------
</TABLE>

IncentiveCompPlan-2000-Full Plan Income

                                       9
<PAGE>

                         Regeneration Technologies, Inc.
                         - Incentive Compensation Plan -

                            Summary of Plan Pay-Outs

Note: Award computation below is at "Budget" Net Profit; "Internal Target" & 10%
above Internal Target

<TABLE>
<CAPTION>
                                                     ------------------------  --------------------------  -------------------------
                                                      At "Budget" Net Profit      At "internal Tar et"         110% over Internal
                                                     ------------------------  --------------------------  -------------------------
                                       ------------                                           $ Pay-Out                   $ Pay-Out
                                           Base        Computed    $ Pay-Out     Computed     at profit     Computed      at profit
                                       Compensation   Pay-Out as   at profit    Pay-Out as  = to Internal  Pay-Out as     = 110% of
                                        by Category   % of Base   = to Budget   % of Base       Target      % of Base    Int. Target
                                       ------------  ------------------------  --------------------------  -------------------------

<S>                                    <C>              <C>         <C>            <C>        <C>              <C>       <C>
RTI Corporate Incentive Plan:
   Executives    CEO/CFO/COO              $570,638       0%               $0       35%          $199,723       57%         $324,040
   Executives    VP's                     $388,170       0%               $0       30%          $116,451       49%         $189,404
   Directors                             1,147,175       0%               $0       25%          $286,794       41%         $465,523
   Managers                              1,757,128       0%               50       15%          $263,569       24%         $429,011
   Exempt                                2,472,026       0%               $0       10%          $247,203       16%         $401,628
   Non-Exempt                            5,825,200       0%               $0        5%          $291,260        8%         $472,369
                                       -----------                                            ----------                 ----------
   Total                               $12,160,337                        $0                  $1,405,000                 $2,281,975

   % of Eligible Payroll -
     Corporate Plan                                                      0.0%                       11.6%                      18.8%

   Sales & Marketing Plan                1,003,000      21%         $209,061       44%          $438,734       66%         $657,421

   Donor Recovery Plan                     192,000      18%          $34,434       21%           $40,510       24%          $46,587
</TABLE>

                                       10

<PAGE>

                         Regeneration Technologies, Inc.
                  Year 2000 Sales and Marketing Incentive Plans

Year 2000 Numbers:

      NOTE: All sales numbers are NET of ACTUAL Returns

      Each plan participant must achieve at least their Baseline on ALL product
      lines in their control, or their total bonus is reduced by 50%

      All awards subject to final review & approval by CEO/CFO

<TABLE>
<CAPTION>

                                              Budget               Internal Target                     Established
                                              Revenue                  Revenue                          Baseline
                                        ------------------        ----------------        ----------------------------------
<S>                                     <C>                       <C>                     <C>               <C>
Sales Dept:
   Jim Abraham Incentive Lines:
      Domestic Non-Spinal Osteofil      $        3,536,160        $      4,018,768        99% of budget     $      3,500,798
      Italy Osteofil                    $           86,736        $        100,080        99% of budget     $         85,869
      Regenafil/form                    $        5,016,221        $      5,700,069        99% of budget     $      4,966,059
      Sports Medicine                   $        5,154,125        $      7,395,125        99% of budget     $      5,102,584
      Conventional (w/ Pericardium)     $       14,454,155        $     16,290,035        99% of budget     $     14,309,613
      SDG Spinal Non-Paste              $       75,028,060        $     83,355,940        99% of budget     $     74,277,779
      SDG Spinal Paste                  $       14,063,231        $     15,981,480        99% of budget     $     13,922,599
      Exactech Opteform                 $        1,319,968        $      1,500,096        99% of budget     $      1,306,768
                                        ------------------        ----------------                          ----------------
                                        $      118,658,656        $    134,341,593                          $    117,472,069

   National Director Incentive Lines:
      Sports Medicine                   $        5,154,125        $      7,395,125        80% of budget     $      4,123,300
      Domestic Non-Spinal Osteofil      $        3,536,160        $      4,018,768        80% of budget     $      2,828,928
      Conventional(w/o O/M Pericard)    $       14,190,000        $     15,990,000        80% of budget     $     11,352,000
                                        ------------------        ----------------                          ----------------
                                        $       22,880,285        $     27,403,893                          $     18,304,228

   Regional Managers Incentive Lines:
      Sports Medicine                   $        5,154,125        $      7,395,125        80% of budget     $      4,123,300
      Domestic Non-Spinal Osteofil      $        3,536,160        $      4,018,768        80% of budget     $      2,828,928
      Conventional(w/o O/M Pericard)    $       14,190,000        $     15,990,000        80% of budget     $     11,352,000

NOTE: Each region's Internal Target
& Budget will need to be estabtished
individually (& the 3 regions must
= the totals above), and then separate
tiered % can be developed for each
region, which in total must =
commission totals above.

   Distribution Manager Incentive Lines:
      Sports Medicine                   $        5,154,125        $      7,395,125        80% of budgot     $      4,123,300
      Conventional                      $       14,454,155        $     16,290,035        80% of budget     $     11,563,324

(Brian & Phil are assumed to be part
of the corporate incentive
compensation plan)

Marketing Dept:
   Oral-Maxillofacial Incentive Lines:
      Regenafil                         $        2,904,096        $      3,300,024        70% of budget     $      2,032,867
      Regenaform                        $        2,112,125        $      2,400,045        70% of budget     $      1,478,488
      Pericardium                       $          264,155        $        300,035        70% of budget     $        184,909
                                        ------------------        ----------------                          ----------------
                                        $        5,280,376        $      6,000,104                          $      3,696,263

   Breakdown of O/M Sales:
      Internal                          $          880,047        $      1,000,000        70% of budget     $        616,033
      Regional 1                        $        1,100,082        $      1,250,026        70% of budget     $        770,057
      Regional 2                        $        1,100,082        $      1,250,026        70% of budget     $        770,057
      Regional 3                        $        1,100,082        $      1,250,026        70% of budget     $        770,057
      Regional 4                        $        1,100,082        $      1,250,026        70% of budget     $        770,057
                                        ------------------        ----------------                          ----------------
                                        $        5,280,375        $      6,000,104                          $      3,696,263
                                        ------------------        ----------------                          ----------------
      Tim: National Manager             $        5,280,375        $      6,000,104        70% of budget     $      3,696,263

<CAPTION>
                                                                 Total             Total
                                            Bonus                Bonus             Bonus
                                          at Budget          at Int Target     at 110% Target            Bonus at Budget
                                         ------------        -------------     --------------     -------------------------------
<S>                                      <C>                 <C>               <C>                <C>
Sales Dept:
   Jim Abraham Incentive Lines:
      Domestic Non-Spinal Osteofil       $          -        $      12,065     $       24,122     0.00% from baseline to "budget"
      Italy Osteofil                     $          -        $         334     $          634     0.00% from baseline to "budget"
      Regenafil/form                     $          -        $       5,129     $       10,829     0.00% from baseline to "budget"
      Sports Medicine                    $          -        $      56,025     $       78,210     0.00% from baseline to "budget"
      Conventional (w/ Pericardium)      $          -        $      36,718     $       85,588     0.00% from baseline to "budget"
      SDG Spinal Non-Paste               $          -        $       3,331     $        6,665     0.00% from baseline to "budget"
      SDG Spinal Paste                   $          -        $       9,591     $       17,582     0.00% from baseline to "budget"
      Exactech Opteform                  $          -        $         901     $        1,651     0.00% from baseline to "budget"
                                         ------------        -------------     --------------
                                         $          -        $     124,093     $     225,280

   National Director Incentive Lines:
      Sports Medicine                    $      3,866        $      26,276     $       37,368     0.375% from baseline to "budget"
      Domestic Non-Spinal Osteofil       $      2,652        $       7,478     $       13,506     0.375% from baseline to "budget"
      Conventional(w/o O/M Pericard)     $     10,643        $      28,643     $       52,628     0.375% from baseline to "budget"
                                         ------------        -------------     --------------
                                         $     17,180        $      62,396     $      103,502

   Regional Managers Incentive Lines:
      Sports Medicine                    $      7,731        $      52,551     $       74,731     0.75% from baseline to "budget"  i
      Domestic Non-Spinal Osteofil       $      5,304        $      14,956     $       21,013     0.75% from baseline to "budget"
      Conventional(w/o O/M Pericard)     $     21,285        $      51,285     $      105,255     0.75% from baseline to "budget"
                                         ------------        -------------     --------------
             Note: The total bonuses
             computed on this line
             are split among all
             three Regional Managers >>  $     34,320        $     124,793     $      207,004

   Distribution Manager Incentive Lines:
      Sports Medicine                    $      1,546        $       8,269     $       11,597     0.15% from baseline to "budget"
      Conventional                       $     14,454        $      28,223     $       44,513     0.50% from baseline to "budget"
                                         ------------        -------------     --------------
                                         $     16,000        $      36,492     $       56,110

Marketing Dept:
   Oral-Maxillofacial Incentive Lines:
      Regenafil
      Regenaform
      Pericardium

   Breakdown of O/M Sales:
      Internal                           $      2,640        $       5,039     $        8,039     1.00% from baseline to "budget"
      Regional 1                         $     33,002        $      37,501     $       41,251     3.00% on all sales
      Regional 2                         $     24,752        $      39,140     $       54,747     7.50% from baseline to "budget"
      Regional 3                         $     24,752        $      39,746     $       54,747     7.50% from baseline to "budget"
      Regional 4                         $     24,752        $      39,746     $       54,747     7.50% from baseline to "budget"
                                         ------------        -------------     --------------
                                         $    109,898        $     161,779     $      213,530
      Tim: National Manager              $     31,682        $      53,274     $       77,275     2.00% from baseline to "budget"
                                         ------------        -------------     --------------
                                         $    141,580        $     215,053     $      290,804

<CAPTION>

                                                   Additional Bonus at Target              Addtl Bonus over Target
                                                ---------------------------------          -----------------------
<S>                                             <C>                                         <C>
Sales Dept:
   Jim Abraham Incentive Lines:
      Domestic Non-Spinal Osteofil         +    2.50% from "budget" to Int Target     +     3.00% over Int Target
      Italy Osteofil                       +    2.50% from "budget" to Int Target     +     3.00% over Int Target
      Regenafil/form                       +    0.75% from "budget" to Int Target     +     1.00% over Int Target
      Sports Medicine                      +    2.50% from "budget" to Int Target     +     3.00% over Int Target
      Conventional (w/ Pericardium)        +    2.00% from "budget" to Int Target     +     3.00% over Int Target
      SDG Spinal Non-Paste                 +    0.04% from "budget" to Int Target     +     0.04% over Int Target
      SDG Spinal Paste                     +    0.50% from "budget" to Int Target     +     0.50% over Int Target
      Exactech Opteform                    +    0.50% from "budget" to Int Target     +     0.50% over Int Target

   National Director Incentive Lines:
      Sports Medicine                      +    1.00% from "budget" to Int Target     +     1.50% over Int Target
      Domestic Non-Spinal Osteofil         +    1.00% from "budget" to Int Target     +     1.50% over Int Target
      Conventional(w/o O/M Pericard)       +    1.00% from "budget" to Int Target     +     1.50% over Int Target

   Regional Managers Incentive Lines:
      Sports Medicine                      +    2.00% from "budget" to Int Target     +     3.00% over Int Target
      Domestic Non-Spinal Osteofil         +    2.00% from "budget" to Int Target     +     3.00% over Int Target
      Conventional(w/o O/M Pericard)       +    2.00% from "budget" to Int Target     +     3.00% over Int Target

   Distribution Manager Incentive Lines:
      Sports Medicine                      +    0.30% from "budget" to Int Target     +     0.45% over Int Target
      Conventional                         +    0.75% from "budget" to Int Target     +     1.00% over Int Target

Marketing Dept:
   Oral-Maxillofacial Incentive Lines:
      Regenafil
      Regenaform
      Pericardium

Breakdown of O/M Sales:
      Internal                             +    2.00% from "budget" to Int Target     +     3.00% over Int Target
      Regional 1
      Regional 2                           +    10.00% from "budget" to Int Target    +     12.00% over Int Target
      Regional 3                           +    10.00% from "budget" to Int Target    +     12.00% over Int Target
      Regional 4                           +    10.00% from "budget" to Int Target    +     12.00% over Int Target

      Tim: National Manager                +    3.00% from "budget" to Int Target     +     4.00% over Int Target
</TABLE>

Discounts:

      In all lines where previous sales history exists, the average discount
      must be maintained in order to achieve the above bonuses.

      If the average sales in any quarterly period are at a discount greater
      than the average, 2.5% of the bonus will be lost for each 1% discount off
      average.

      If the average sales in any quarterly period are 5% or more ABOVE the
      average, the bonus will be increased by 10% (new bonus will = 110% x
      normal bonus).

      The term "average discount" means the average discount off of catalog
      pricing within the region for the preceding 6-month period.
<PAGE>

                         Regeneration Technologies, Inc.

           Year 2000 National Accounts / Donor Recovery Incentive Plan

Field Staff Incentives:

      1. For signing a new account, or conversion of competitor account -

            Payout of a bonus based on the size & avg recovery cost of the
            program, as per the following table:

<TABLE>
<CAPTION>
                ------------------------------------------------------------------------------------------------------------------
                                                       Program with                 Program with                   Program with
                                                Greater than or equal to 7  Less than 7 but Greater than 15        Less than 15
                                                       donors/month                donors/month                    donors/month
                ------------------------------------------------------------------------------------------------------------------
                  <S>                                   <C>                        <C>                            <C>
                  More than 10% under the
                  current avg per-donor cost            $500/donor                  $750/donor                        $1,250/donor
                ------------------------------------------------------------------------------------------------------------------
                  At avg per-donor cost, or up
                  to 9% under current avg               $350/donor                  $500/donor                        $750/donor
                ------------------------------------------------------------------------------------------------------------------
                  Over the current avg per-
                  donor cost                            $125/donor                  $175/donor                        $200/donor
                ------------------------------------------------------------------------------------------------------------------
</TABLE>

            Rules:

                  a.    For a new program, payout is initially based on
                        agreed-upon estimates (& paid upon closing), with
                        adjustment at end of year one for actual performance of
                        the program, using actual months 7-12 multiplied by two
                        (annualized).
                  b.    For a conversion program, payout is initially based on
                        agreed-upon estimates (& paid upon closing), with
                        adjustment at end of six months for actual performance,
                        using actual months 1-6 multiplied by two (annualized).
                  c.    Finance will provide quarterly updates to National
                        Accounts of the "average per-donor cost" of RTI recovery
                        programs.
                  d.    "Donors" are whole donors as defined in recovery
                        contracts, plus "equivalent whole" for partial donors

      2. For all accounts assigned in territory, monthly bonus for each donor
         over the total target for those accounts.
                  -----------------------------
                  $50 per donor over the target
                  -----------------------------
            Rules:

                  a.    Targets for all accounts under management to be
                        reviewed, & modified if needed, quarterly with Director
                  b.    All targets to be revised annually
                  c.    Targets will exclude certain accounts, at discretion of
                        Director, such as UFTB, Tutogen. etc.

      3. Funeral Home Program:
                  ------------------------------------------------------------
                  $100 per donor for more than 5 donors per month from funeral
                  homes in territory
                  ------------------------------------------------------------

      4. Medical Examiner Heart Recovery Program:
                  ------------------------------------------------------------
                  $100 per donor for more than 2 heart recoveries per month from
                  medical examiners in territory
                  ------------------------------------------------------------

      5. Management Services Agreement Program:
                  ------------------------------------------------------------
                  $1,000 for executing any MSA with more than 5 donors per
                  month, at a cost per-donor < or = current avg cost
                  ------------------------------------------------------------

Support Staff Incentives:

      For all National Accounts (all territories), monthly bonus for exceeding
      the total National Accounts target for the month
                  --------------------------
                  $100 for each staff person
                  --------------------------
            Rules:

                  a.    Targets will be set by Director, subject to Director
                        discretion
                  b.    All targets to be revised annually, or more often at
                        Director discretion
                  c.    Target will exclude certain accounts (ie., Tutogen)

Other Awards:

      Chairman's Award of Excellence (Quarterly) -

                  Excellence in Orthopedic Donor Recovery
                  Excellence in Soft Tissue Donor Recovery
                  Excellence in Cardiovascular Donor Recovery

                                      -12-<PAGE>

                                                                   Exhibit 10.25

Exhibit 10.25 License and Distribution Agreement Between View Systems, Inc. and
Visionics Corporation, dated April 12, 2000

                      VALUED ADDED RESELLER (VAR) AGREEMENT

         This Agreement is made as of April 12th, of 2000, by View Systems,
Inc., a corporation organized under the laws of Florida ("VAR"), with offices at
9693 Gerwig Lane, Suite O, Columbia, Md. 21046 and Visionics Corporation, a
corporation organized under the laws of New Jersey ("Licensor"), with offices at
1 Exchange Place, Jersey City, NJ 07302 USA.

WHEREAS, Licensor owns or controls the rights in and to the Licensed Technology
(as defined below), consisting of the FaceIt Application (as defined below) and
the FaceIt API (as defined below);

WHEREAS, the FaceIt Application provides face detection and recognition
functionality to various types of products and services and the FaceIt API can
be used to embed such functionality into such products and services;

WHEREAS, VAR desires to obtain from Licensor, and Licensor desires to grant to
VAR, a license (as defined below, the "License") to use the Licensed Technology
for the purpose of developing, selling, and distributing to third parties in
accordance with and subject to all of the provisions of this Agreement products
and/or services into which the functionality of the FaceIt Application has been
embedded (defined below as "VAR Developed Products");

NOW, THEREFORE, for the consideration stated in this Agreement, the parties
hereby agree as follows:

                                   SECTION 1.
                                   DEFINITIONS

         The following words shall, where the context allows, have the following
meanings whether such words shall appear in lower case or with the first letter
of each word capitalized:

         1.1 "FACEIT APPLICATION" shall mean that certain library of algorithms,
database structures, data and related items of software that provides face
detection and recognition functionality in the products and services into which
such library is embedded through the use of the FaceIt API, and which set
comprises [in part] the FaceIt Developer Kit (SDK) version 3.0 or upgrades
thereto issued within one year of the effective date of this Agreement.

                                     II-15
<PAGE>

         1.2 "FACEIT API" shall mean that certain applications programming
interface for integrating the FaceIt Application in various products and
services, and which applications programming interface comprises [in part] the
FaceIt Developer Kit (SDK) version 3.0 or upgrades thereto issued within one
year of the effective date of this Agreement.

         1.3 "INTELLECTUAL PROPERTY RIGHTS" with respect to any item of
intellectual property shall mean the patent, copyright, trade secret, trade
mark, service mark, trade dress, mask work and other like rights in such item.

         1.4 "LICENSED TECHNOLOGY" shall mean the FaceIt Application and the
FaceIt API, together comprising . the FaceIt Developer Kit (SDK) version 3.0 or
upgrades thereto issued within one year of the effective date of this Agreement.

         1.5 "LICENSOR LOGOS" shall mean the FaceIt logo(s) and/or expression
"with FaceIt-Registered Trademark- Technology" or "with Visionics'
FaceIt-Registered Trademark- technology" or "with FaceIt-Registered
Trademark- Face Recognition Technology" and equivalent expressions of the
foregoing that acknowledge that the face detection and recognition technology
to which such expressions relate is the FaceIt Application from Licensor.

         1.6 "TERRITORY" shall mean the World.

         1.7 "VAR DEVELOPED PRODUCTS (VDPS)" shall mean the products and
services into which VAR embeds the FaceIt Application through use of the FaceIt
API subject to and in accordance with the terms and conditions of this
Agreement, and which products and services are described in Appendix A to this
Agreement.

                                   SECTION 2.
                                GRANT OF LICENSE

         2.1 For the term of this Agreement, Licensor hereby grants to VAR and
VAR hereby accepts a limited, non-exclusive license throughout the Territory to
embed the FaceIt Application in VDPs through the use of the FaceIt API under the
Windows 95/98/NT/2000 Operating System and solely for the purpose of
distributing, selling, and marketing the VDPs with the FaceIt Application so
embedded therein; PROVIDED, HOWEVER, that VAR shall not have the right to
sublicense the Licensed Technology, by any means, except as incorporated in
VDPs.

         2.2 As a condition to the exercise of the license granted in paragraph
2.1 above, VAR shall place one or more Licensor Logos where appropriate, in the
reasonable judgment of Licensor, in VDP packaging and advertising and CGI
scripts, screens, forms and the like comprising the VDP, with all such use

                                     II-16
<PAGE>

to inure to the benefit of Licensor and its suppliers. Reasonably prior to the
first publication of the Licensor Logo on any such packaging, advertisements and
CGI scripts, session screens, forms and the like during the term of this
Agreement, VAR will provide Licensor with copies or samples of such materials
for the purpose of allowing Licensor to comment on the format and appearance of
the Licensor Logo in such materials, and VAR shall use commercially reasonable
efforts to incorporate Licensor's comments in such materials prior to the
publication thereof.

         2.3 Notwithstanding any other provisions contained in this Agreement,
Licensor and its suppliers reserve all rights in the Licensed Technology, the
Licensor Logos, and the Intellectual Property comprising the Licensed Technology
and the Licensor Logos, in each case not expressly granted herein to VAR.

                                   SECTION 3.
                             LICENSOR'S OBLIGATIONS

         3.1 Licensor shall deliver to VAR a copy of the FaceIt Developer Kit's
(SDK) version 3.0 for Identification and verification, within ten (10) business
days following the execution of this Agreement. Licensor will invoice VAR for
the FaceIt Developer Kit (SDK) in the amount of US$11,748. VAR shall pay all
amounts due pursuant to such invoice within 60 days of receipt of such invoice.

         3.2 During the term of this Agreement, Licensor shall supply VAR (at no
additional cost to VAR) with all upgrades to and patches directed at bugs in the
Licensed Technology that it generally provides free of charge to its licensees.

         3.3 From time to time during the term of this Agreement, Licensor, at
its sole and absolute discretion, may modify the Licensed Technology in response
to one or more written requests from VAR. In consideration thereof, VAR shall
pay to Licensor the invoiced charges for such modifications in accordance with
the schedule of fees and expenses set forth in Schedule 7.1, which such schedule
may be changed from time to time by Licensor upon written notice to VAR.

                                   SECTION 4.
                               VAR'S OBLIGATIONS

         4.1 VAR shall, subject to the terms of this Agreement, use its
reasonable commercial efforts to manufacture the VDP and promote, exploit and
sell it throughout the Territory.

         4.2 VAR shall cause copyright, patent and trademark notices to appear
on or within each unit of the VDP and each item of packaging and promotional
material and each CGI script, screen, form and the like comprising VDP user
sessions as described in

                                     II-17
<PAGE>

Section 2.2. This Section 4.2 shall be applicable only when a VDP includes
Licensed Technology.

         4.3 VAR shall cooperate with Licensor in protecting the Licensed
Technology, at Licensor's expense, and shall promptly supply Licensor, at
Licensor's expense, with any information or materials reasonably required by
Licensor. If VAR is notified in writing or becomes aware of any unauthorized use
of the Licensed Technology in the Territory, VAR shall so advise Licensor.
Licensor may, in its discretion, take, or elect not to take, such action as it
deems advisable against any infringing party. If Licensor fails, or elects not
to take action against an infringing party within ninety (90) days after receipt
by Licensor of VAR's notice to Licensor of such unauthorized use, VAR shall have
the right, at VAR's expense, to commence an action against the infringer in
VAR's name and in Licensor's name and Licensor shall cooperate with VAR, at
VAR's expense, in connection therewith. VAR shall not enter into any settlements
of any such actions commenced by VAR with respect to the Licensed Technology
without Licensor's consent.

         4.4 VAR agrees to create and/or license the VDP such that a single copy
of the VDP: (a) is used for analysis on a single video input at any given time,
(b) is used on a single machine, and not in a multiple client/server
architecture, with head finding, template creation and face matching functions
performed on such single machine, (c) is licensed for use for up to 200 images
or faces stored within a list, subject to the corresponding fees set forth in
Schedule 7.1, (d) is used for the purpose of physical access control (supplying
identification of an individual for physical access to a facility) (e) is used
for the explicit purpose of supplementing existing access control mechanisms,
and (f) is not designed for, sold to, nor specifically targets the law
enforcement, surveillance, banking or travel industry segments (collectively,
"Core Application")..

                                   SECTION 5.
                               PROPRIETARY RIGHTS

         5.1 Licensor or its suppliers shall own all of the Intellectual
Property Rights and other rights to the Licensed Technology, and VAR shall not
challenge, or cause any third party to challenge, the rights of Licensor or its
suppliers anywhere in the world.

         5.2 VAR shall own all of the Intellectual Property Rights and other
rights to any packaging, advertising and promotional material produced by VAR
for the VDP only to the extent that they are not derivative works of the
Licensed Technology. VAR acknowledges that it is not, by virtue of this
Agreement, acquiring

                                     II-18
<PAGE>

from Licensor the right to create or utilize derivative works from the Licensed
Technology except as provided in Section 2.1.

         5.3 Each party hereto shall keep in confidence and not disclose to any
third party, without the written permission of the other party the terms of this
Agreement and the proprietary information of each party made known to the other
under this Agreement including any and all portions of the Licensed Technology,
and any information about the suppliers, pricing and business of the other
party. This requirement of confidentiality shall not apply to information that
is (a) in the public domain through no wrongful act of the receiving party; (b)
rightfully received by the receiving party from a third party who is not bound
by a restriction of nondisclosure; or (c) is required to be disclosed by
applicable rules and regulations of government agencies or judicial bodies,
provided that the disclosing party is provided reasonably sufficient notice to
contest or limit such required disclosure.

                                   SECTION 6.
                                TERM OF AGREEMENT

         6.1 The term of this Agreement shall commence upon the date of this
Agreement and shall expire two years following the initial shipment of a VDP
that incorporates the Licensed Technology in the Territory by VAR or two and a
half years from the date of this Agreement, which ever is shorter . VAR shall
inform Licensor of the date of initial shipment of VDP in the Territory. This
agreement may be renewed for successive one year periods upon the mutual written
agreement of the parties and after a performance review to be conducted no later
than 6 months before the then current date of expiration of this Agreement.

                                   SECTION 7.
                              PAYMENT OF ROYALTIES

         7.1 VAR shall pay to Licensor royalties in accordance with Schedule 7.1
annexed hereto which is incorporated and made a part hereof ("Royalties") by
check or wire transfer in U.S. Dollars, according to instructions given to VAR
by Licensor. VAR will bear all related bank charges. Any late payment will
accrue interest at a rate of 1.5% per month. VAR will pay any late payment
charge upon remitting the principal amount to Licensor.

         7.2 Statements as to Royalties shall be sent by VAR to Licensor within
30 days following the end of each quarterly calendar period for such preceding
quarterly period together with payment of Royalties, if any, shown to be due
thereon.

                                     II-19
<PAGE>

         7.3 All statements of Royalties and all other accountings rendered by
VAR hereunder shall be subject to objection, stating the basis thereof, by
Licensor within three (3) years after the date rendered (including after
termination or expiration of this Agreement).

         7.4 VAR shall maintain, at its executive offices in 9693 Gerwig Lane,
Suite O, Columbia, Md. 21046, books of account concerning sales of the VDP and
the Licensed Technology. Licensor or its agent may, at Licensor's sole expense,
examine VAR's said books relating to the sale of the VDP and the Licensed
Technology hereunder for the purpose of verifying the accuracy thereof, during
VAR's normal business hours and upon reasonable written notice. Such books
relating to any particular royalty statement may be examined as aforesaid only
within two years after the date rendered. Licensor shall notify VAR in writing
within 90 days after such examination if Licensor believes that VAR's books are
not accurate. Licensor and its agents shall keep all information obtained in
such examination confidential and use such information solely for the purpose of
this paragraph.

         7.5 Licensor may change the List Prices as defined in Schedule 7.1,
Maintenance Fees and Upgrade Fees, in whole or in part, at any time upon no less
that 90 days prior notice to VAR, subject to any binding commitment that
Licensor has made to VAR, but only if Licensor generally applies such changes to
its other VARs. Licensor may also increase the Product Discount, Maintenance
Discount or Upgrade Discount upon no less that 30 days prior notice to VAR. Any
reduction of such discounts will require VARs consent.

         7.6 All amounts payable by VAR under this Agreement are exclusive of
any tax, levy or similar governmental charge that may be assessed by any
jurisdiction, whether based on gross revenue, the delivery, possession or use of
VAR's products, the execution or performance of this Agreement or otherwise,
except for net income, net worth or franchise taxes assessed on VAR outside of
the Territory. If, under the laws of the Territory, VAR is required to withhold
any taxes on such payments, then the amount of the payment will be automatically
increased to totally offset such tax, so that the amount actually remitted to
Licensor , net of all taxes, equals the amount invoiced or otherwise due. VAR
with promptly furnish Licensor with the official receipt of payment of these
taxes to the appropriate taxing authority. VAR will pay all other taxes, levies
or similar governmental charges or provide Licensor with a certificate of
exemption acceptable to the taxing authority.

                                   SECTION 8.

                                     II-20
<PAGE>

                 REPRESENTATIONS AND WARRANTIES/INDEMNIFICATION

         8.1 Each party represents and warrants to the other that this Agreement
has been duly authorized, executed and delivered by it; it has the full power
and authority and is free to enter into this Agreement and to perform its
obligations hereunder; this Agreement constitutes its valid and binding
obligation, enforceable in accordance with its terms; and the making of this
Agreement does not violate any agreement, right or obligation existing between
it and any other person, firm or corporation, on the other hand.

         8.2 VAR represents and warrants to Licensor that the VDP does not and
will not infringe the Intellectual Property Rights and other proprietary rights
of any third party. VAR further represents and warrants to Licensor that the VDP
and the Licensed Technology will be manufactured in accordance with industry
standards for similar products, and, to the best of its knowledge, will (i) be
free of defects and (ii) not be harmful to the property or person of third
parties. VAR will handle in a professional manner any end user or distributor
inquiries or complaints regarding the Licensed Technology.

         8.3 Licensor represents and warrants that the Licensed Technology and
any materials created or added to the Licensed Technology by Licensor does not
and will not infringe the Intellectual Property Rights and other proprietary
rights of any third party.

         8.4 Each party shall indemnify, defend and hold harmless the other (and
the other's officers, directors, and affiliated companies) from and against all
liabilities, damages, costs or expenses (including reasonable attorney's fees)
payable or paid by the indemnified party to a third party as a result of a
breach or alleged breach by the indemnifying party of its representation and
warranty contained in Section 8.2 or Section 8.3, as the case may be, of this
Agreement. The party asserting any claim to indemnification under this Section
8.4 shall promptly notify the other party of any such claim or proceeding and
shall not settle any such claim or proceeding without the indemnifying party's
prior written consent. The indemnified party shall have the right at its expense
to participate in the defense thereof with counsel of its choice, provided that
the indemnifying party shall have the right at all times to retain or resume
control of the conduct of such defense. This indemnification obligation shall
survive for two years after termination or expiration of this Agreement.

         8.5 Licensor warrants that the Licensed Technology, in its unaltered
form, will, for a period of 90 days from its installation date conform
substantially to the then-current published functional specification of the
Licensed Technology, provided such Licensed Technology is used in the manner
consistent

                                     II-21
<PAGE>

with any applicable Licensor minimum Hardware and Software configuration
specifications that have been supplied by Licensor to VAR. Licensor will make
reasonable efforts to correct errors reflecting material deviations from the
functional specifications as are reported by License to Licensor during such
warranty period. Because not all errors in Licensed Technology can or need be
corrected in order for the Licensed Technology to operate in accordance with the
applicable specifications, Licensor does not warrant that all Licensed
Technology defects will be corrected. Similarly, Licensor does not warrant that
the Licensed Technology will meet VAR's or its customers' requirements, that the
Licensed Technology will operate in combinations selected for use by VAR or
customer or that use of the Licensed Technology will be uninterrupted or
error-free.

         8.6 VAR shall indemnify, defend and hold harmless the Licensor (and
Licensor's officers, directors, and affiliated companies) from and against all
liabilities, damages, costs or expenses (including reasonable attorney's fees)
payable or paid by the indemnified party to a third party as a result of any
claim that the use of the Licensed Technology in the VDP or otherwise by VDP
then has resulted, results or may result in any deprivation or violation of the
constitutional, statutory, contractual, common law or other rights of any
person. The party asserting any claim to indemnification under this Section 8.6
shall promptly notify VAR of any such claim or proceeding and shall not settle
any such claim or proceeding without VAR's prior written consent. The
indemnified party shall have the right at its expense to participate in the
defense thereof with counsel of its choice, provided that the indemnifying party
shall have the right at all times to retain or resume control of the conduct of
such defense. This indemnification obligation shall survive termination or
expiration of this Agreement.

                                   SECTION 9.
                                   TERMINATION

         9.1     9.1. Upon expiration of the term of this Agreement, all rights
granted to VAR hereunder shall immediately and without further action by
Licensor revert to Licensor. VAR shall not thereafter manufacture, advertise,
distribute or sell Licensed Technology; provided, however, that VAR may sell off
on a non-exclusive basis existing inventories of the Licensed Technology for a
period of six (6) months, subject to all the other terms and conditions hereof.
In respect of any sales by VAR of Licensed Technology during such six-month
period after expiration or other termination of this Agreement, VAR shall
continue to pay all royalties that become due and payable hereunder and VAR
shall send to Licensor within thirty (30) days following the last day of such
six-month period a statement and final payment of Royalties.

                                     II-22
<PAGE>

         9.2 Either party may terminate this Agreement in the event that (1) the
other party materially breaches its obligations hereunder, which breach remains
uncured following 30 days notice from the nonbreaching party, or (2) bankruptcy,
insolvency or reorganization proceedings, or other proceedings analogous in
nature or effect, are instituted against the other party or by the other party
with respect to itself. For purposes of this Agreement, the failure of VAR to
render statements and payment of Royalties in accordance with the terms of this
Agreement shall be deemed to be a material breach of VAR's obligations
hereunder. Either party may terminate this Agreement at any time upon 60 days
notice.

         9.3 The following sections shall survive any termination or expiration
of this Agreement: Sections 1, 5, 7, 8.2, 8.3, 8.4, 8.6, 9.1, 9.3, 10 and 11.

                                  SECTION 10.
                             LIMITATION OF LIABILITY

         10.1 VAR agrees to include an appropriate end-user license in its VDP
that is as protective of Licensor's rights as is this Agreement and in the form
set forth in Schedule 10.1 attached hereto.

         10.2 Except for the indemnity obligations arising out of Section 8.4
and 8.6, under no circumstances will either party be liable for any
consequential, indirect, special, punitive or incidental damages or lost
profits, whether foreseeable or unforeseeable (including, but not limited to,
claims for loss or data, goodwill, use of money or use of the Licensed
Technology, interruption in use or availability of data, stoppage of other work
or impairment or other assets), arising out of breach or failure of express or
implied warranty or condition, breach of contract, misrepresentation,
negligence, strict liability in tort, or otherwise. Except for the indemnity
obligations arising out of Section 8.4 and 8.6, in no event will the aggregate
liability which either party may incur in any action or proceeding exceed the
total amount actually paid to Licensor by VAR hereunder. Under no circumstance
shall Licensor be liable for any actions, claims or the like by VAR or any third
party that the use of the Licensed Technology has resulted, results or may
result in any deprivation or violation of the constitutional, statutory,
contractual, common law or other rights of any person. This section will not
apply in the event and to the extent that applicable law specifically prohibits
the limitation of liability set forth in this Section 10.2.

                                  SECTION 11.

                                     II-23
<PAGE>

                            MISCELLANEOUS PROVISIONS

         11.1 NOTICES. All notices, statements and payments to be sent to the
parties hereunder shall be addressed to the parties at the addresses set forth
on the first page hereof or at such other address as the parties shall designate
in writing from time to time. All notices shall be in writing and shall either
be served by personal delivery (to an officer of each company), mail, or
facsimile (if confirmed by mail or personal delivery of the hard copy), all
charges prepaid. Except as otherwise provided herein, such notices shall be
deemed given when received. Copies of all notices to Licensor should be sent to
Licensor at its address set forth above, attention: Dr. Joseph Atick.

         11.2 NO ASSIGNMENT. VAR shall not have the right to assign any of its
rights or obligations hereunder.

         11.3 SCOPE OF AGREEMENT AND AMENDMENT. The entire understandings
between the parties hereto relating to the subject matter hereof are contained
herein. There are no representations, warranties, terms, conditions,
undertakings or collateral agreements, express, implied or statutory, between
the parties other than as expressly set forth in this Agreement. This Agreement
cannot be changed, modified, amended or terminated except by an instrument in
writing executed by both VAR and Licensor. All Schedules, which may be attached
hereto, constitute a part of this Agreement and are incorporated herein by this
reference.

         11.4 NO WAIVER. No waiver, modification or cancellation of any term or
condition of this Agreement shall be effective unless executed in writing by the
party charged therewith. No written waiver shall excuse the performance of any
act other than those specifically referred to therein and shall not be deemed or
construed to be a waiver of such terms or conditions for the future or any
subsequent breach thereof.

         11.5 RELATIONSHIP OF PARTIES. This Agreement does not constitute a
partnership or joint venture between Licensor and VAR. Neither VAR nor Licensor
shall have any right, power or authority to obligate or bind the other in any
manner whatsoever, except as provided for in this Agreement, and nothing herein
contained shall give or is intended to give any rights of any kind to any third
persons.

         11.6 APPLICABLE LAWS. This Agreement shall be governed by the laws of
New Jersey applicable to contracts made and to be wholly performed therein
(without regard to choice of law).

         11.7 ARBITRATION. In the event of any dispute or controversy hereunder
(including, without limitation, any dispute

                                     II-24
<PAGE>

involving the existence, validity or breach of this Agreement), the parties
shall submit same to arbitration privately and confidentially in New York, New
York pursuant to the Commercial Arbitration Rules of the American Arbitration
Association by three arbitrators, one of whom shall be appointed by Licensor,
one of whom shall be appointed by VAR and one of whom shall be appointed by the
first two arbitrators, subject to each such arbitrator executing an appropriate
confidentiality agreement. The result of any such arbitration shall be binding
but shall not be made public unless necessary to confirm same after
non-compliance by a party.

         11.8 SEVERABILITY. If any provision of this Agreement is or becomes or
is deemed invalid, illegal or unenforceable under the applicable laws or
regulations of any jurisdiction, then either such provision will be deemed
amended to conform to such laws or regulations without materially altering the
intention of the parties or it shall be stricken and the remainder of this
Agreement shall remain in full force and effect.

         11.9 APPROVAL AND CONSENT. Wherever the approval or consent of a party
is required hereunder, such approval or consent shall not be unreasonably
withheld.

         11.10 COMPETING PRODUCTS. VAR agrees not to represent, market,
distribute or sell any product which is in direct competition to any of the
Licensor's products or services. A list of products or vendors known to be in
competition with the products as of the effective date of this Agreement is
attached hereto in Exhibit G.

         11.11 NO CONFLICT OF INTEREST. The parties represent and warrant that
they have full power and authority to undertake the obligations set forth in
this Agreement and that they have not entered into any other agreements that
would render them incapable of satisfactorily performing their obligations
hereunder.

         11.12 COMPLIANCE WITH LAW. The parties agree that they shall comply
with all applicable laws and regulations of governmental bodies or agencies in
their performance under this Agreement.

         11.13 COUNTERPARTS. This Agreement may be executed in counterparts,
each of which shall be deemed an original Agreement for all purposes and which
collectively shall constitute one and the same Agreement.

                                     II-25
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have signed this Agreement as of
the day and year first above written.

VIEW SYSTEMS, INC.

By:______________________________________
Its:_____________________________________

VISIONICS CORPORATION

By:______________________________________
Its:_____________________________________

                                     II-26
<PAGE>

                                  SCHEDULE 7.1

                                ROYALTY SCHEDULE

Visionics will receive royalties based on the following model:

1.   Royalty based on a fee equal to $200 per copy of the Licensed Technology
     incorporated into the VDP by check or wire transfer in U.S. Dollars, as
     stipulated in section 7.2.

2.   For applications outside the Core Application listed in Section 4.3 of this
     Agreement, VAR and Licensor shall structure in good faith an alternative
     pricing model to be determined at a later date.

3.   In consideration of the terms listed above, VAR agrees to a minimum royalty
     payment in the amount of $20,000 per year. The minimum royalty payment
     shall be pro-rated to a quarterly payment of $5,000 and is due 30 days
     after the close of each quarter. The accounting period shall coincide with
     the fiscal accounting period.

4.   VAR and Licensor agree to reassess the licensing structure/including
     minimum royalty payments after 6 months (to asses market acceptance)

5.   Maintenance Fees: Visionics 12-month maintenance fee of 15% on SDK and on
     unites installed where customer has elected to receive maintenance
     (upgrades/enhancements).

                                     II-27
<PAGE>

    APPENDIX A

                              CAREVIEW DESCRIPTION

         Captures video output from cameras, digitizes it, stores it, transmits
it and runs computer programs and functions against it, including facial
recognition, for purposes of physical access control.

                                     II-28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00008-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00008-of-00352.parquet"}]]